UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 218

Sortiert nach

The efficacy and safety of a third anti‐TNF monoclonal antibody in Crohn’s disease after failure of two other anti‐TNF antibodies

Alimentary pharmacology & therapeutics, 2010-01, Vol.31 (1), p.92-101

2010

Link zum Volltext

Verfügbarkeit prüfen

Adalimumab maintenance therapy for Crohn’s disease with intolerance or lost response to infliximab: an open‐label study

Alimentary pharmacology & therapeutics, 2007-03, Vol.25 (6), p.675-680

2007

Link zum Volltext

Verfügbarkeit prüfen

Long‐term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single‐centre experience

Alimentary pharmacology & therapeutics, 2008-10, Vol.28 (8), p.966-972

2008

Link zum Volltext

Verfügbarkeit prüfen

Long‐term outcome of non‐fistulizing (ulcers, stricture) perianal Crohn’s disease in patients treated with infliximab

Alimentary pharmacology & therapeutics, 2009-10, Vol.30 (7), p.749-756

2009

Link zum Volltext

Verfügbarkeit prüfen

Methotrexate for psoriasiform lesions associated with anti-tumour necrosis factor therapy in inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2012-05, Vol.35 (10), p.1175-1180

2012

Link zum Volltext

Verfügbarkeit prüfen

Additional benefit of procalcitonin to C‐reactive protein to assess disease activity and severity in Crohn’s disease

Alimentary pharmacology & therapeutics, 2010-11, Vol.32 (9), p.1135-1144

2010

Link zum Volltext

Verfügbarkeit prüfen

Infliximab for refractory ulcerative proctitis

Alimentary pharmacology & therapeutics, 2010-06, Vol.31 (11), p.1178-1185

2010

Link zum Volltext

Verfügbarkeit prüfen

Adalimumab for Crohn’s disease with intolerance or lost response to infliximab: a 3‐year single‐centre experience

Alimentary pharmacology & therapeutics, 2009-02, Vol.29 (4), p.416-423

2009

Link zum Volltext

Verfügbarkeit prüfen

Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease

Gut, 2010-08, Vol.59 (8), p.1056-1065

2010

Link zum Volltext

Verfügbarkeit prüfen

Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results

Alimentary pharmacology & therapeutics, 2003-02, Vol.17 (3), p.333-341

2003

Link zum Volltext

Verfügbarkeit prüfen

Interaction of ribavirin with azathioprine metabolism potentially induces myelosuppression

Alimentary pharmacology & therapeutics, 2008-10, Vol.28 (8), p.984-993

2008

Link zum Volltext

Verfügbarkeit prüfen

The role of acid suppression in patients with endoscopy‐negative reflux disease: the effect of treatment with esomeprazole or omeprazole

Alimentary pharmacology & therapeutics, 2004-08, Vol.20 (4), p.413-421

2004

Link zum Volltext

Verfügbarkeit prüfen

Patient-to-Patient Transmission of Hepatitis C Virus during Colonoscopy

The New England journal of medicine, 1997-07, Vol.337 (4), p.237-240

1997

Link zum Volltext

Verfügbarkeit prüfen

Easy clip to treat anal fistula tracts: a word of caution

International journal of colorectal disease, 2015-05, Vol.30 (5), p.621-624

2015

Link zum Volltext

Verfügbarkeit prüfen

Tumour necrosis factor antagonists and inflammatory bowel diseases: a national practice survey

Alimentary pharmacology & therapeutics, 2009-10, Vol.30 (8), p.854-863

2009

Link zum Volltext

Verfügbarkeit prüfen

Treatment of patients with heartburn without endoscopic evaluation: on‐demand treatment after effective continuous administration of lansoprazole 15 mg

Alimentary pharmacology & therapeutics, 2005-10, Vol.22 (7), p.635-643

2005

Link zum Volltext

Verfügbarkeit prüfen

Symptomatic gastro-oesophageal reflux disease: Double blind controlled study of intermittent treatment with omeprazole or ranitidine

BMJ. British medical journal (International ed.), 1999-02, Vol.318 (7182), p.502

International edition, 1999

Link zum Volltext

Verfügbarkeit prüfen

Certolizumab use in pregnancy

Gut, 2009-04, Vol.58 (4), p.608-608

2009

Link zum Volltext

Verfügbarkeit prüfen

One‐week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori in patients with non‐ulcer dyspepsia: influence of dosage of omeprazole and clarithromycin

Alimentary pharmacology & therapeutics, 1998-04, Vol.12 (4), p.383-388

1998

Link zum Volltext

Verfügbarkeit prüfen

Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4‐year Study of 127 French Patients

Cancer, 1994-07, Vol.74 (1), p.16-24

1994

Link zum Volltext

Verfügbarkeit prüfen

Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease

Gut, 2011-07, Vol.60 (7), p.930-936

2011

Link zum Volltext

Verfügbarkeit prüfen

Comparison of resection, liver transplantation and transcatheter oily chemoembolization in treatment of hepatocellular carcinoma

Journal of hepatology, 1996-03, Vol.24 (3), p.293-300

1996

Link zum Volltext

Verfügbarkeit prüfen

Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results

Alimentary pharmacology & therapeutics, 2003-02, Vol.17 (s1), p.24-24

2003

Link zum Volltext

Verfügbarkeit prüfen

Boceprevir for Untreated Chronic HCV Genotype 1 Infection

The New England journal of medicine, 2011-03, Vol.364 (13), p.1195-1206

2011

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis of lipid malabsorption in patients with chronic pancreatitis: a new indirect test using postprandial plasma apolipoprotein B-48

The American journal of gastroenterology, 1999-11, Vol.94 (11), p.3229-3235

1999

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 218

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(124)
Mit Volltextzugriff
(100)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(142)
Male
(81)
Female
(71)
Middle Aged
(71)
Life Sciences & Biomedicine
(66)
Science & Technology
(66)
Adult
(65)
Gastroenterology & Hepatology
(45)
Biological And Medical Sciences
(42)
Medical Sciences
(42)
Aged
(41)
Gastroenterology. Liver. Pancreas. Abdomen
(25)
Treatment Outcome
(21)
Pharmacology. Drug Treatments
(20)
Other Diseases. Semiology
(19)
Digestive System
(18)
Adolescent
(17)
Double-Blind Method
(17)
Pharmacology & Pharmacy
(17)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(17)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The efficacy and safety of a third anti‐TNF monoclonal antibody in Crohn’s disease after failure of two other anti‐TNF antibodies

Adalimumab maintenance therapy for Crohn’s disease with intolerance or lost response to infliximab: an open‐label study

Long‐term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single‐centre experience

Long‐term outcome of non‐fistulizing (ulcers, stricture) perianal Crohn’s disease in patients treated with infliximab

Methotrexate for psoriasiform lesions associated with anti-tumour necrosis factor therapy in inflammatory bowel disease

Additional benefit of procalcitonin to C‐reactive protein to assess disease activity and severity in Crohn’s disease

Infliximab for refractory ulcerative proctitis

Adalimumab for Crohn’s disease with intolerance or lost response to infliximab: a 3‐year single‐centre experience

Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease

Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results

Interaction of ribavirin with azathioprine metabolism potentially induces myelosuppression

The role of acid suppression in patients with endoscopy‐negative reflux disease: the effect of treatment with esomeprazole or omeprazole

Patient-to-Patient Transmission of Hepatitis C Virus during Colonoscopy

Easy clip to treat anal fistula tracts: a word of caution

Tumour necrosis factor antagonists and inflammatory bowel diseases: a national practice survey

Treatment of patients with heartburn without endoscopic evaluation: on‐demand treatment after effective continuous administration of lansoprazole 15 mg

Symptomatic gastro-oesophageal reflux disease: Double blind controlled study of intermittent treatment with omeprazole or ranitidine

Certolizumab use in pregnancy

One‐week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori in patients with non‐ulcer dyspepsia: influence of dosage of omeprazole and clarithromycin

Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4‐year Study of 127 French Patients

Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease

Comparison of resection, liver transplantation and transcatheter oily chemoembolization in treatment of hepatocellular carcinoma

Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results

Boceprevir for Untreated Chronic HCV Genotype 1 Infection

Diagnosis of lipid malabsorption in patients with chronic pancreatitis: a new indirect test using postprandial plasma apolipoprotein B-48

Suchergebnisse filtern